GD-134

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameGD-134
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H4 receptor antagonistsHistamine H1 receptor antagonists
TargetsHistamine H4 receptorHistamine H1 receptor
Therapy Area/IndicationsConjunctivitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGriffin Discoveries BV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGriffin Discoveries BV
Active IndicationsN/A
Inactive IndicationsConjunctivitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A